Year |
Citation |
Score |
2008 |
Kim S, Morley JF, Ben-Zvi A, Morimoto RI. Polyglutamine Aggregates as a Model for Protein-misfolding Diseases Protein Folding Handbook. 3: 1175-1199. DOI: 10.1002/9783527619498.ch69 |
0.745 |
|
2007 |
Brignull HR, Morley JF, Morimoto RI. The stress of misfolded proteins: C. elegans models for neurodegenerative disease and aging. Advances in Experimental Medicine and Biology. 594: 167-89. PMID 17205684 DOI: 10.1007/978-0-387-39975-1_15 |
0.68 |
|
2006 |
Brignull HR, Morley JF, Garcia SM, Morimoto RI. Modeling polyglutamine pathogenesis in C. elegans. Methods in Enzymology. 412: 256-82. PMID 17046663 DOI: 10.1016/S0076-6879(06)12016-9 |
0.677 |
|
2004 |
Morley JF, Morimoto RI. Regulation of longevity in Caenorhabditis elegans by heat shock factor and molecular chaperones. Molecular Biology of the Cell. 15: 657-64. PMID 14668486 DOI: 10.1091/Mbc.E03-07-0532 |
0.56 |
|
2002 |
Morley JF, Brignull HR, Weyers JJ, Morimoto RI. The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proceedings of the National Academy of Sciences of the United States of America. 99: 10417-22. PMID 12122205 DOI: 10.1073/Pnas.152161099 |
0.666 |
|
Low-probability matches (unlikely to be authored by this person) |
2014 |
Trinh J, Amouri R, Duda JE, Morley JF, Read M, Donald A, Vilariño-Güell C, Thompson C, Szu Tu C, Gustavsson EK, Ben Sassi S, Hentati E, Zouari M, Farhat E, Nabli F, et al. Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism. Neurobiology of Aging. 35: 1125-31. PMID 24355527 DOI: 10.1016/j.neurobiolaging.2013.11.015 |
0.289 |
|
2012 |
Morley JF, Duda JE. Parkinson's disease and the risk of cerebrovascular pathology. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1471-2. PMID 23033113 DOI: 10.1002/mds.25179 |
0.208 |
|
2010 |
Morley JF, Duda JE. Olfaction as a biomarker in Parkinson's disease. Biomarkers in Medicine. 4: 661-70. PMID 20945979 DOI: 10.2217/bmm.10.95 |
0.201 |
|
2020 |
Spotorno N, Coughlin DG, Olm CA, Wolk D, Vaishnavi SN, Shaw LM, Dahodwala N, Morley JF, Duda JE, Deik AF, Spindler MA, Chen-Plotkin A, Lee EB, Trojanowski JQ, McMillan CT, et al. Tau pathology associates with in vivo cortical thinning in Lewy body disorders. Annals of Clinical and Translational Neurology. PMID 33108692 DOI: 10.1002/acn3.51183 |
0.199 |
|
2022 |
Miller-Patterson C, Hsu JY, Chahine LM, Morley JF, Willis AW. Selected autonomic signs and symptoms as risk markers for phenoconversion and functional dependence in prodromal Parkinson's disease. Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society. PMID 36057046 DOI: 10.1007/s10286-022-00889-8 |
0.196 |
|
2019 |
Mantri S, Duda JE, Morley JF. Early and Accurate Identification of Parkinson Disease Among US Veterans. Federal Practitioner : For the Health Care Professionals of the Va, Dod, and Phs. 36: S18-S23. PMID 31296979 |
0.184 |
|
2017 |
Brennan L, Devlin KM, Xie SX, Mechanic-Hamilton D, Tran B, Hurtig HH, Chen-Plotkin A, Chahine LM, Morley JF, Duda JE, Roalf DR, Dahodwala N, Rick J, Trojanowski JQ, Moberg PJ, et al. Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class Analysis. Journal of Parkinson's Disease. PMID 28387684 DOI: 10.3233/Jpd-171081 |
0.184 |
|
2011 |
Morley JF, Weintraub D, Mamikonyan E, Moberg PJ, Siderowf AD, Duda JE. Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2051-7. PMID 21611985 DOI: 10.1002/mds.23792 |
0.182 |
|
2021 |
Walker IM, Fullard ME, Morley JF, Duda JE. Olfaction as an early marker of Parkinson's disease and Alzheimer's disease. Handbook of Clinical Neurology. 182: 317-329. PMID 34266602 DOI: 10.1016/B978-0-12-819973-2.00030-7 |
0.182 |
|
2014 |
Morley JF, Pawlowski SM, Kesari A, Maina I, Pantelyat A, Duda JE. Motor and non-motor features of Parkinson's disease that predict persistent drug-induced Parkinsonism. Parkinsonism & Related Disorders. 20: 738-42. PMID 24742370 DOI: 10.1016/j.parkreldis.2014.03.024 |
0.177 |
|
2012 |
Morley JF, Xie SX, Hurtig HI, Stern MB, Colcher A, Horn S, Dahodwala N, Duda JE, Weintraub D, Chen-Plotkin AS, Van Deerlin V, Falcone D, Siderowf A. Genetic influences on cognitive decline in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 512-8. PMID 22344634 DOI: 10.1002/Mds.24946 |
0.168 |
|
2010 |
Morley JF, Hurtig HI. Current understanding and management of Parkinson disease: five new things. Neurology. 75: S9-15. PMID 21041778 DOI: 10.1212/WNL.0b013e3181fb3628 |
0.167 |
|
2009 |
Morley JF, Duda JE. Autopsy investigation of neurodegenerative disease transplant patients: hindsight is 20/20. Neurology. 73: 1086-7. PMID 19726748 DOI: 10.1212/WNL.0b013e3181bc6758 |
0.165 |
|
2012 |
Milber JM, Noorigian JV, Morley JF, Petrovitch H, White L, Ross GW, Duda JE. Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease. Neurology. 79: 2307-14. PMID 23152586 DOI: 10.1212/Wnl.0B013E318278Fe32 |
0.164 |
|
2022 |
Aamodt WW, Dubroff JG, Cheng G, Taylor B, Wood S, Duda JE, Morley JF. Gait abnormalities and non-motor symptoms predict abnormal dopaminergic imaging in presumed drug-induced Parkinsonism. Npj Parkinson's Disease. 8: 53. PMID 35484281 DOI: 10.1038/s41531-022-00309-8 |
0.161 |
|
2018 |
Mantri S, Morley JF, Siderowf AD. The importance of preclinical diagnostics in Parkinson disease. Parkinsonism & Related Disorders. PMID 30224266 DOI: 10.1016/j.parkreldis.2018.09.011 |
0.157 |
|
2022 |
Vaswani PA, Morley JF, Jennings D, Siderowf A, Marek K. Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS study. Parkinsonism & Related Disorders. 104: 15-20. PMID 36194902 DOI: 10.1016/j.parkreldis.2022.09.007 |
0.155 |
|
2019 |
Deck BL, Xie SX, Choi G, Rick J, Siderowf A, Rudovsky S, Chen-Plotkin A, Duda JE, Morley JF, Dahodwala N, Trojanowski JQ, Weintraub D. Cognitive Functional Abilities in Parkinson's Disease: Agreement Between Patients and Informants. Movement Disorders Clinical Practice. 6: 440-445. PMID 31392244 DOI: 10.1002/Mdc3.12781 |
0.152 |
|
2012 |
Morley JF, Duda JE. Head injury and the risk of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1592-4. PMID 23192921 DOI: 10.1002/mds.25230 |
0.145 |
|
2014 |
Morley JF, Duda JE. Use of hyposmia and other non-motor symptoms to distinguish between drug-induced Parkinsonism and Parkinson's disease Journal of Parkinson's Disease. 4: 169-173. PMID 24284418 DOI: 10.3233/JPD-130299 |
0.14 |
|
2019 |
Mantri S, Wood S, Duda JE, Morley JF. Comparing self-reported and objective monitoring of physical activity in Parkinson disease. Parkinsonism & Related Disorders. 67: 56-59. PMID 31621608 DOI: 10.1016/j.parkreldis.2019.09.004 |
0.137 |
|
2016 |
Wilkinson JR, Spindler M, Wood SM, Marcus SC, Weintraub D, Morley JF, Stineman MG, Duda JE. High patient satisfaction with telehealth in Parkinson disease: A randomized controlled study. Neurology. Clinical Practice. 6: 241-251. PMID 27347441 DOI: 10.1212/CPJ.0000000000000252 |
0.134 |
|
2015 |
Hellman AM, Shah SP, Pawlowski SM, Duda JE, Morley JF. Continuous non-invasive monitoring to detect covert autonomic dysfunction in Parkinson's disease. Parkinsonism & Related Disorders. 21: 723-8. PMID 25940998 DOI: 10.1016/j.parkreldis.2015.04.016 |
0.13 |
|
2016 |
Brennan L, Pantelyat A, Duda JE, Morley JF, Weintraub D, Wilkinson JR, Moberg PJ. Memantine and Cognition in Parkinson's Disease Dementia/Dementia With Lewy Bodies: A Meta-Analysis. Movement Disorders Clinical Practice. 3: 161-167. PMID 30363483 DOI: 10.1002/Mdc3.12264 |
0.129 |
|
2019 |
Mantri S, Wood S, Duda JE, Morley JF. Understanding physical activity in Veterans with Parkinson disease: A mixed-methods approach. Parkinsonism & Related Disorders. 61: 156-160. PMID 31036158 DOI: 10.1016/j.parkreldis.2018.10.023 |
0.128 |
|
2022 |
Walker IM, Cousins KA, Siderowf A, Duda JE, Morley JF, Dahodwala N, Tropea T, Vaishnavi S, Wolk DA, Chen-Plotkin AS, Shaw LM, Lee EB, Trojanowski JQ, Grossman M, Weintraub D, et al. Non-tremor motor dysfunction in Lewy body dementias is associated with AD biomarkers. Parkinsonism & Related Disorders. 100: 33-36. PMID 35700626 DOI: 10.1016/j.parkreldis.2022.05.022 |
0.123 |
|
2020 |
Gallagher J, Rick J, Xie SX, Martinez-Martin P, Mamikonyan E, Chen-Plotkin A, Dahodwala N, Morley J, Duda JE, Trojanowski JQ, Siderowf A, Weintraub D. Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's Disease. Journal of Parkinson's Disease. PMID 33386814 DOI: 10.3233/JPD-202390 |
0.122 |
|
2018 |
Mantri S, Fullard ME, Duda JE, Morley JF. Physical Activity in Early Parkinson Disease. Journal of Parkinson's Disease. 8: 107-111. PMID 29480222 DOI: 10.3233/JPD-171218 |
0.121 |
|
2011 |
Morley JF, Duda JE. Neuropsychological correlates of olfactory dysfunction in Parkinson's disease. Journal of the Neurological Sciences. 310: 228-30. PMID 21658728 DOI: 10.1016/j.jns.2011.05.030 |
0.121 |
|
2023 |
Vaswani PA, Morley JF, Jennings D, Siderowf A, Marek K. Predictive value of abbreviated olfactory tests in prodromal Parkinson disease. Npj Parkinson's Disease. 9: 103. PMID 37386033 DOI: 10.1038/s41531-023-00530-z |
0.12 |
|
2023 |
Waddell KJ, Patel MS, Wilkinson JR, Burke RE, Bravata DM, Koganti S, Wood S, Morley JF. Deploying Digital Health Technologies for Remote Physical Activity Monitoring of Rural Populations With Chronic Neurologic Disease. Archives of Rehabilitation Research and Clinical Translation. 5: 100250. PMID 36968173 DOI: 10.1016/j.arrct.2022.100250 |
0.119 |
|
2014 |
Cheng G, Morley JF. Complete and readily reversible blocking of striatal DaTscan binding by methylphenidate. Clinical Nuclear Medicine. 39: 211-3. PMID 24300364 DOI: 10.1097/RLU.0000000000000307 |
0.119 |
|
2020 |
Caroff SN, Jain R, Morley JF. Revisiting amantadine as a treatment for drug-induced movement disorders. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 32: 198-208. PMID 32722730 |
0.115 |
|
2016 |
Fullard ME, Tran B, Xie SX, Toledo JB, Scordia C, Linder C, Purri R, Weintraub D, Duda JE, Chahine LM, Morley JF. Olfactory impairment predicts cognitive decline in early Parkinson's disease. Parkinsonism & Related Disorders. PMID 26923521 DOI: 10.1016/J.Parkreldis.2016.02.013 |
0.113 |
|
2021 |
Howard E, Irwin DJ, Rascovsky K, Nevler N, Shellikeri S, Tropea TF, Spindler M, Deik A, Chen-Plotkin A, Siderowf A, Dahodwala N, Weintraub D, Shaw LM, Trojanowski JQ, Vaishnavi SN, ... ... Morley JF, et al. Cognitive Profile and Markers of AD-Type Pathology in Patients with Lewy Body Dementias. Neurology. PMID 33593865 DOI: 10.1212/WNL.0000000000011699 |
0.11 |
|
2018 |
Morley JF, Cohen A, Silveira-Moriyama L, Lees AJ, Williams DR, Katzenschlager R, Hawkes C, Shtraks JP, Weintraub D, Doty RL, Duda JE. Optimizing olfactory testing for the diagnosis of Parkinson's disease: item analysis of the university of Pennsylvania smell identification test. Npj Parkinson's Disease. 4: 2. PMID 29354684 DOI: 10.1038/s41531-017-0039-8 |
0.108 |
|
2017 |
Morley JF, Cheng G, Dubroff JG, Wood S, Wilkinson JR, Duda JE. Olfactory Impairment Predicts Underlying Dopaminergic Deficit in Presumed Drug-Induced Parkinsonism. Movement Disorders Clinical Practice. 4: 603-606. PMID 30363414 DOI: 10.1002/mdc3.12458 |
0.1 |
|
2017 |
Fullard ME, Morley JF, Duda JE. Olfactory Dysfunction as an Early Biomarker in Parkinson's Disease. Neuroscience Bulletin. PMID 28831680 DOI: 10.1007/s12264-017-0170-x |
0.099 |
|
2020 |
Purri R, Brennan L, Rick J, Xie SX, Deck BL, Chahine LM, Dahodwala N, Chen-Plotkin A, Duda JE, Morley JF, Akhtar RS, Trojanowski JQ, Siderowf A, Weintraub D. Subjective Cognitive Complaint in Parkinson's Disease Patients with Normal Cognition: Canary in the Coal Mine? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32520435 DOI: 10.1002/Mds.28115 |
0.098 |
|
2021 |
Forbes E, Tropea TF, Mantri S, Xie SX, Morley JF. Modifiable Comorbidities Associated with Cognitive Decline in Parkinson's Disease. Movement Disorders Clinical Practice. 8: 254-263. PMID 33553496 DOI: 10.1002/mdc3.13143 |
0.093 |
|
2017 |
Deck BL, Rick J, Xie SX, Chen-Plotkin A, Duda JE, Morley JF, Chahine LM, Dahodwala N, Trojanowski JQ, Weintraub D. Statins and Cognition in Parkinson's Disease. Journal of Parkinson's Disease. PMID 28922167 DOI: 10.3233/Jpd-171113 |
0.084 |
|
2008 |
Morley JF, Kolson DL. Frontal encephalocele in a middle-aged woman with first seizure: smells like a seizure to me. Neurology. 70: 157. PMID 18180446 DOI: 10.1212/01.Wnl.0000296822.59839.38 |
0.079 |
|
2021 |
Hsiao CY, Morley J. Debt and financial market contagion. Empirical Economics. 1-50. PMID 34149150 DOI: 10.1007/s00181-021-02077-5 |
0.072 |
|
2015 |
Pigott K, Rick J, Xie SX, Hurtig H, Chen-Plotkin A, Duda JE, Morley JF, Chahine LM, Dahodwala N, Akhtar RS, Siderowf A, Trojanowski JQ, Weintraub D. Longitudinal study of normal cognition in Parkinson disease. Neurology. PMID 26362285 DOI: 10.1212/Wnl.0000000000002001 |
0.071 |
|
2010 |
Wusthoff CJ, Kranick SM, Morley JF, Christina Bergqvist AG. The ketogenic diet in treatment of two adults with prolonged nonconvulsive status epilepticus. Epilepsia. 51: 1083-5. PMID 19845731 DOI: 10.1111/j.1528-1167.2009.02388.x |
0.071 |
|
1996 |
Liang BT, Morley JF. A new cyclic AMP-independent, Gs-mediated stimulatory mechanism via the adenosine A2a receptor in the intact cardiac cell. The Journal of Biological Chemistry. 271: 18678-85. PMID 8702522 DOI: 10.1074/Jbc.271.31.18678 |
0.07 |
|
2023 |
Morley J, Rodríguez-Palenzuela D, Sun Y, Wong B. Estimating the euro area output gap using multivariate information and addressing the COVID-19 pandemic. European Economic Review. 153: 104385. PMID 36714546 DOI: 10.1016/j.euroecorev.2023.104385 |
0.066 |
|
2022 |
Kannarkat GT, Caroff SN, Morley JF. Risk of Drug-induced Movement Disorders with Newer Antipsychotic Agents. Tremor and Other Hyperkinetic Movements (New York, N.Y.). 12: 19. PMID 35836971 DOI: 10.5334/tohm.695 |
0.052 |
|
2015 |
Sharer JD, Leon-Sarmiento FE, Morley JF, Weintraub D, Doty RL. Olfactory dysfunction in Parkinson's disease: Positive effect of cigarette smoking. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 859-62. PMID 25545729 DOI: 10.1002/mds.26126 |
0.051 |
|
2021 |
Englander M, Morley J. Phenomenological psychology and qualitative research. Phenomenology and the Cognitive Sciences. 1-29. PMID 34744533 DOI: 10.1007/s11097-021-09781-8 |
0.049 |
|
2015 |
Morley J. A phenomenologist's response to Alan Waterman. The American Psychologist. 69: 88-9. PMID 24446850 DOI: 10.1037/a0034866 |
0.047 |
|
1987 |
Piner EW, Morley JF. EVOLUTION OF A NEW RANGE OF TELECOUNTING INSTRUMENTS FOR DIAL-UP DATA TRANSMISSION EMPLOYING THE SERIAL-CODED TELE-METERING TECHNIQUE. Iee Conference Publication. 76-80. |
0.031 |
|
2021 |
Forbes E, Vaswani PA, Duda JE, Morley JF. Uremic Striatopallidal Syndrome Manifesting as Acute Onset Chorea. Movement Disorders Clinical Practice. 8: S55-S57. PMID 34514054 DOI: 10.1002/mdc3.13285 |
0.019 |
|
2021 |
Lang AE, Forbes E, Vaswani PA, Duda JE, Morley JF, Sethi KD. Commentary: Uremic Striatopallidal Syndrome Manifesting as Acute Onset Chorea. Movement Disorders Clinical Practice. 8: S58-S59. PMID 34514055 DOI: 10.1002/mdc3.13299 |
0.018 |
|
1990 |
Morley JF. New concept for original register value transmission for metering applications Iee Conference Publication. 149-153. |
0.014 |
|
2019 |
Morley J. Phenomenology in nursing studies: New perspectives - Commentary. International Journal of Nursing Studies. 93: 163-167. PMID 30824109 DOI: 10.1016/j.ijnurstu.2019.02.002 |
0.013 |
|
1932 |
Riley HL, Morley JF, Friend NAC. 255. Selenium dioxide, a new oxidising agent. Part I. Its reaction with aldehydes and ketones Journal of the Chemical Society (Resumed). 1875-1883. DOI: 10.1039/JR9320001875 |
0.01 |
|
Hide low-probability matches. |